Company: XERI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001477932-25-003761
Chunk: 48

Company: XERIANT, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 48
---
Amortization of right of use asset  32,253   37,463 Prepaids  7,142   (3,155)Accounts payable and accrued liabilities  (82,184)  866,168 Accrued liabilities, related party  (16,000)  (12,500)Shares to be issued  27,750   - Lease liability  (36,197)  (41,316)Net cash from operating activities  (1,116,530)  (1,059,894)         Cash Flows from Investing Activities        Cash issued for notes receivable  -   (139,947)Cash repayments for notes receivable  -   131,784 Net cash from financing activities  -   (8,163)         Cash Flows from Financing Activities        Proceeds from convertible bridge loans  517,000   1,380,000 Net cash from financing activities  517,000   1,380,000          Net change in cash  (599,530)  311,943          Cash at beginning of period  653,117   61,625          Cash at end of period $53,587  $373,568          Supplemental Cash Flow Information        Cash paid for interest $-  $- Cash paid for income taxes $-  $-          Non-cash investing and financing activities:        Conversion of convertible notes payable and accrued interest $(42,488) $321,115 Cashless exercise of warrants $15  $- Warrants issued with convertible notes payable $-  $6,666 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 F-6Table of Contents

XERIANT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2025

UNAUDITED

NOTE 1 - ORGANIZATION AND NATURE OF BUSINESS Company Overview Xeriant, Inc. (the “Company”) is dedicated to the discovery, development and commercialization of disruptive technologies in advanced materials and aerospace which can be successfully integrated and commercialized for deployment across multiple industrial sectors